Abstract
Lymphocyte reactions are complex and involve interactions between lymphocyte subsets and accessory cells and a number of soluble molecules that they produce. A major contribution to the study of T-cell biology was provided by the observations of Morgan et al. (1976) that a cytokine, then designated as T-cell growth factor (TCGF), released into conditioned media of lectin-stimulated mononuclear cells could support the long-term growth of T cells in a culture system. This has led to the development of homogeneous clones of various T-cell subsets that permitted functional studies of T-cell subsets, their capacity to produce various effector and immunoregulatory molecules, mechanisms of interactions with various growth and inhibitory factors, and requirement for various molecules for their own growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abo, T., Miller, C. A., Balch, C. M., and Cooper, M. D., 1983, Interleukin-2 receptor expression by activated HNK 1+ granular lymphocytes. A requirement for their proliferation, J. Immunol. 131: 1822–1826.
Alcocer-Varela, J., and Alarcon-Segovia, D., 1982, Decreased production and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus, J. Clin. Invest. 69: 1388–1392.
Alcocer-Varela, J., Laffon, A., and Alarcon-Segovia, D., 1983, Specific monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus, Clin. Exp. Imunol. 54: 125–132.
Alcocer-Varela, J., Laffon, A., and Alarcon-Segovia, D., 1984, Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases, Rheumatol. Int. 4: 39–44.
Altman, A., Theofilopoulos, A. N., Weiner, R., Katz, K. M., and Dixon, F. J., 1981, Analysis of T cell function in autoimmune murine strain. Defects in production of and responsiveness to interleukin-2, J. Exp. Med. 154: 791–808.
Andrew, M. E., Braciale, V. L., and Braciale, T. J., 1984, Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones, J. Immunol. 132: 839–844.
Auron, P. E., Webb, A. C., Rossenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., and Dinarello, C. A., 1984, Nucleotide sequence of human monocyte interleukin-1 precursor DNA, Proc. Natl. Acad. Sci. U.S.A. 81: 7907–7911.
Baker, P. E., Fahey, J., and Munck, A., 1981, Prostaglandin inhibition of T-cell proliferation is mediated at low levels, Cell Immunol. 61: 52–61.
Bettens, F., Kristensen, F., Walker, C., Bonnard, G. D., and DeWeck, A. L., 1984, Lymphokine regulation of human lymphocyte proliferation: Formation of resting G0 cells by removal of interleukin-2 in cultures of proliferating T lymphocytes, Cell. Immunol. 86: 337–346.
Bitterman, P. B., Rennard, S. I., Hunninghake, G. W., and Crystal, R. G., 1982, Human alviolar macrophage growth factor for fibroblasts. Regulation and partial characterization, J. Clin. Invest. 70: 806.
Blyden, G., and Handschumacher, R. E., 1977, Purification and properties of human lymphocyte activating factor (LAF), J. Immunol. 118: 1631–1638.
Bodel, P. T., and Hollingsworth, J. W., 1968, Pyrogen release from human synovial exudate cells, Br. J. Exp. Pathol. 49: 11–19.
Bonnard, G. D., Yasaka, K., and Maca, R. D., 1980, Continuous growth of functional human T Lymphocytes: Production of human T cell growth factor, Cell. Immunol. 51: 390–401.
Booth, R. J., and Watson, J. D., 1984, Interleukin-1 induces proliferation in two distinct B cell subpopulations responsive to two different murine B cell growth factors, J. Immunol. 133: 1346–1349.
Boraschi, D., Censini, S., and Tagliabue, A., 1984, Interferon-2 reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin-1 production, J. Immunol. 133: 764–768.
Cantor, H., 1981, Regulation of immune responses: Analysis with lymphocyte clones, Cell 25: 7–8.
Chandy, K. G., DeCoursey, T. E., Cahalan, M. D., McLanghlin, C., and Gupta, S., 1984, Voltage-gated potassium channels are required for human T lymphocyte activation, J. Exp. Med. 160: 369–385.
Chandy, K. G., DeCoursey, T. E., Cahalan, M. D., and Gupta, S., 1985a, Electroimmunity: The physiological role of ion channels in the immune system, J. Immunol, (in press).
Chandy, K. G., DeCoursey, T. E., Cahalan, M. D., and Gupta, S., 1985b, Ion channels in T lymphocytes, J. Clin. Immunol. 5: 1–7.
Dauphinee, M. J., Kipper, S. B., Wofsy, D., and Talal, N., 1981a, Interleukin-2 deficiency is a common feature of autoimmune mice, J. Immunol. 127: 2483–2487.
Dauphinee, M. J., Kipper, S., Roskos, K., Wofsy, D., and Talal, N., 1981b, Deficient interleukin-2 activity in MRL/MP and C57B1/6J mice bearing Lpr gene, J. Exp. Med. 154: 1671–1680.
Davidson, W. F., Roths, J. B., Holmes, K. L., Rudikoft, E., and Morse IE, H. C., 1984, Dissociation of severe lupus-like disease from polyclonal B cell activation and IL-2 Deficiency in C3H-1pr/1pR mice, J. Immunol. 133: 1048–1056.
Dayer, J. M., Krane, S. M., Russel, R. G. G., and Robinson, D. R., 1976, Production of collagenase and prostaglandin by isolated adherent rheumatoid synovial cells, Proc. Natl. Acad. Sci. U.S.A. 73: 945–949.
Dayer, J. M., Breard, J., Chess, L., and Krane, S. M., 1979, Participation of monocyte-macrophage and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin released by rheumatoid synovial cells, J. Clin. Invest. 64: 1384–1392.
Dayer, J. M., Passwell, J. H., Schneeberger, E. F., and Krane, S. M., 1980, Interactions among rheumatoid synovial cells and monocyte-macrophages: 1. Description and partial biochemical analysis, J. Exp. Med. 142: 151–160.
Dayer, J. M., Stephenson, M. L., Schmidt, E., Karge, W., and Krane, S. M., 1981, Purification of a factor from human blood monocytes macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissue, FEBS Lett. 124: 253–256.
DeCoursey, T. E., Chandy, K. G., Gupta, S., and Cahalan, M. D., 1984, Voltage gated K+ channel in human T lymphocytes: A role in mitogenesis? Nature 307: 465–468.
Dempsey, R. A., Dinarello, C. A., Mier, J. W., Rosenwasser, L. J., Allegrelta, M., Brown T. E., and Parkinson, D. R., 1982, The differentiation effects of human leukocytic pyrogen/lymphocyte human activating factor, T cell growth factor and interferon on human natural killer activity, J. Immunol. 129: 2504–2510.
Dennert, G., Yogeeswaran, G., and Yamagata, S., 1981, Cloned cell lines with natural killer activity: Specificity, function and cell surface markers, J. Exp. Med. 153: 545–556.
Depper, J. M., Leonard, W. J., Kronke, M., Waldmann, T. A., and Greene, W. C., 1984a, Augmentated T cell growth factor receptor expression in HTLV 1-infected human leukemic T cells, J. Immunol. 133: 1691–1695.
Depper, J. M., Leonard, W. J., Kronke, M., Noguchi, P. D., Cunningham, R. E., Waldmann, T. A., and Greene, W. C., 1984, Regulation of interleukin-2 receptor expression: Effect of phorbol diester, phospholipase C and reexposure to lectin or antigen, J. Immunol. 133: 3054–3061.
Devos, R., Plaetinck, G., Cheronte, H., Simons, G., Degrave, W., Traverniere, J., Remout, E., and Fiers, W., 1983, Molecular cloning of human interleukin-2 cDNA and its expression in E. coli, Nucleic Acid Res. 11: 4307–4323.
Dinarello, C. A., 1984a, Interleukin 1, Rev. Infect. Dis. 6: 51–95.
Dinarello, C. A., 1984b, Interleukin 1 and the pathogenesis of the acute phase response, N. Engl. J. Med. 311: 1413–1418.
Dinarello, C. A., and Wolff, S. M., 1982, Molecular basis of fever in humans, Am. J. Med. 72:799–819,
Dinarello, C. A., Clowes, Jr., G. H. A., Gordon, H., Saraves, C. A., and Wolff, S. M., 1984, Cleavage of human interleukin 1: Isolation of a peptide fragment from plasma of febrile humans and activated monocytes, J. Immunol. 133: 1332–1338.
Dingle, J. T., 1984, The role of cellular interactions in joint erosions, Clin. Orthoped. 182: 24–30.
Emery, P., Panayi, G. S., and Nouri, A. E. E., 1984, Interleukin-2 reverses deficient cell mediated immune responses in rheumatoid arthritis, Clin. Exp. Immunol. 57: 123–129.
Erfat, S., Pilo, S., and Kaempfer, R., 1982, Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma interferon, Nature 297: 236–239.
Estes, J. E., Pledger, W. J., and Gillespie, G. Y., 1984, Macrophage-derived growth factor for fibroblasts and interleukin-1 are distinct entities, J. Leuko. Biol. 35: 115–129.
Falkoff, R. J. M., Butler, J. L., Dinarello, C. A., and Fauci, A. S., 1984, Direct effects of a monoclonal B cell differentiation factor and of purified interleukin-1 on B cell differentiation, J. Immunol. 133: 692–696.
Farrar, W. L., Johnson, H. M., and Farrar, J. J., 1981, Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2, J. Immunol. 126: 1120.
Fleisher, T. A., Greene, W. C., Uchiama, T., Goldman, C. K., Nelson, D. L., Blaese, R. M., and Waldmann, T. A., 1981, Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line, J. Exp. Med. 154: 156–167.
Flynn, A., Finke, J. H., and Hilfiker, M. L., 1982, Placental mononuclear phagocytes as a source of interleukin- I, Science 218: 475–477.
Fontana, A., Hengartner, H., Weber, E., Fehr, K., Grob, P. J., and Cohen, G., 1982, Interleukin-1 activity in synovial fluid of patients with rheumatoid arthritis, Rheumatol. Int. 2: 49–53.
Fontana, A., Hengartner, H., DeTribolet, N., and Weber, E., 1984, Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2-mediated effects, J. Immunol. 132: 1837–1844.
Fresno, M., Nabel, G., McVay-Boudreau, L., Furthmayer, H., and Cantor, H., 1981a, Antigen-specific T lymphocyte clones. I. Characterization of a T cell clone expressing antigen-specific suppressive activity, J. Exp. Med. 153: 1245–1259.
Fresno, M., McVay-Boudreau, L., Nabel, G., and Cantor, H., 1981b, Antigen-specific T lymphocyte clones. II. Purification and biological characterization of an antigen-specific suppressive protein synthesized by cloned T cells, J. Exp. Med. 153: 1260–1274.
Fujita, T., Takaoka, C., Matsui, H., and Taniguchi, T., 1983, Structure of the human interleukin-2 gene, Proc. Natl. Acad. Sci. U.S.A. 80: 7437–7441.
Galili, U., Rosenthal, L., Galili, N., and Klein, E., 1979, Activated T cells in the synovial fluid of arthritis patients: Characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity, J. Immunol. 122: 878–883.
Gillis, S., 1983, Interleukin-2: Biology and biochemistry, J. Clin. Immunol. 3: 1–13.
Gillis, S., and Smith, K. A., 1977, Long-term culture of tumor specific cytotoxic T cells, Nature 268: 154.
Gillis, S., Ferm, M. M., Ou, W., and Smith, K. A., 1978, T cell growth factor: Parameters for production and a quantitative microassay for activity, J. Immunol. 120: 2027–2032.
Gillis, S., Crabtree, G. R., and Smith, K. A., 1979, Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte transformation, J. Immunol. 123: 1624–1631.
Gillis, S., Baker, P. E., Union, N. A., and Smith, K. A., 1979b, The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes, J. Exp. Med. 149: 1460–1476.
Gillis, S., Scheid, M., and Watson, J., 1980, The isolation and characterization of interleukin-2 producing T cell lymphoma, J. Immunol. 125: 2570–2578.
Giri, J. G., Kincade, P. W., and Mizel, S. B., 1984, Interleukin-1 mediated induction of K-light-chain synthesis and surface immunoglobulin expression on pre-B cells, J. Immunol. 132: 223–228.
Gonzalez-Amaro, R., Alcocer-Varela, J., Martinez-Cordero, E., and Alarcon-Segovia, D., 1984, Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2, J. Clin. Immunol. 4: 273–279.
Goodman, M. G., Chenoweth, D. E., and Weigle, W. O., 1982, Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptor, J. Exp. Med. 156: 912–917.
Gootenberg, J. E., Ruscetti, F. W., Mier, J. W., Gazdar, A., and Gallo, R. C., 1981, Human cutaneous T cell lymphoma and leukemic cell lines produce and respond to T cell growth factor, J. Exp. Med. 154: 1403–1418.
Greene, W. C., and Robb, R. J., 1984, Receptors for T cell growth factor Structure, function, and expression on normal and neoplastic cells, Contemp. Top. Mol. Immunol. 10: 1–34.
Greene, W. C., Robb, R. J., Depper, J. M., Leonard, W. J., Drogula, C, Svetlik, P. B., Wong-Staal, F., Gallo, R. C., and Waldmann, T. A., 1984, Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells, J. Immunol. 133: 1042–1047.
Gupta, S., Chandy, K. G., DeCoursey, T. E., and Cahalan, M. D., 1984, Role of potassium channels in interleukin 2 synthesis and interleukin 2 receptor expression, Lymphokine Res. 3: 246.
Gupta, S., Chandy, K. G., Vayuvegula, B., Rhulig, L., DeCoursey, T. E., and Cahalan, M. D., 1985, Role of potassium channels in interleukin 1 and interleukin 2. Synthesis and interleukin 2 receptor expression, in: Cellular and Molecular Biology of Lymphokines (C. Sorg and A. Schnimpl, eds.), Academic Press, New York (in press).
Harwell, L. B., Skidmore, B., Marrack, P., and Kappler, J. W., 1980, Concanavalin A inducible interleukin- 2 producing T-cell hybridoma, J. Exp. Med. 152: 893–904.
Hefeneider, S. M., Conlon, P. F., Dower, S. K., Henney, C. S., and Gillis, S., 1984, Limiting dilution analysis of interleukin-2 and colony-stimulating factor producer cells in normal and autoimmune mice, J. Immunol. 132: 1863–1868.
Henderson, L. E., Hewetson, J. F., Hopkins, R. F. Ill, Sowder, R. C., Neubauer, R. H., and Rabin, H., 1983, A rapid, large scale purification procedure for gibbon interleukin-2, J. Immunol. 131: 810–815.
Henney, C. S., Kuribaysashi, K., Kern, D. E., and Gillis, S., 1981, Interleukin-2 augments natural killer cell activity, Nature 291: 335–338.
Hirano, T., Fujimoto, K., Teranishi, T., Nishino, N., Onoue, K., Maeda, S., and Shimada, K., 1984, Phorbol ester increases the level of interleukin-2 mRNA in mitogen-stimulated human lymphocytes, J. Immunol. 312: 2165–2167.
Hoffman, M., 1980, Macrophages and T cells control distinct phases of B cell differentiation in the humoral immune responses in vitro, J. Immunol. 125: 2076–2081.
Howard, M., Matis, L. Malek, T. R., Sevach, E., Kell, W., Cohen, D., Nakanishi, K., and Paul, W. E., 1983, Interleukin-2 induces antigen-reactive T cell lines to secrete BCGF-1, J. Exp. Med. 158: 2024–2039.
Iscove, N. N., 1978, Erythropoietin-independent stimulation of early erythropoiesis in adult bone marrow cultures by condition media from lectin-stimulated mouse spleen cells, in: Hematopoietic Cell Differentiation ( D. Golde, M. J. Cline, D. Metcalf, and C Fox, eds.), Academic Press, New York, pp. 37–52.
Ise, K., Nakamura, S., Ohkamura, S., and Yoshinaga, M., 1982, DNA synthesis-potentiating activity on mouse thymocytes of synovial fluid of rheumatoid arthritis patients, Acta Pathol. Jpn. 32: 49–503.
Johnson, G. R., and Metcalf, D., 1977, Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin, Proc. Natl. Acad. Sci. U.S.A. 74: 3879–3882.
Kaplan, D. R., Braciale, V. L., and Braciale, T. J., 1984, Antigen-dependent regulation of interleukin-2 receptor expression on cloned human cytotoxic T lymphocytes, J. Immunol. 133: 1966–1969.
Kaye, J., Gillis, S., Mizel, S. B., Shevaeh, E. M., Malek, T. R., Dinarello, C. A., Lachman, L. B., and Janeway, C. A., 1984, Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: Interleukin-1 is required for the expression of receptors for interleukin-2, J. Immunol. 133: 1339–1345.
Kern, E. E., Gillis, S., Okada, M., and Henney, C. S., 1981, The role of interleukin-2 (IL-2) in the differ-entiation of cytotoxic T cells: The effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines, A Immunol. 127: 1323–1328.
Keystone, E. C., Shore, A., Miller, R. G., Tan, P., Poplouski, L., Leary, P., and Albert, S., 1983, Evidence for activated peripheral blood T cells in rheumatoid arthritis, J. Rheumatol. 11 (Suppl): 85–92.
Klempner, M. S., Dinarello, C. A., and Gallin, J. L., 1978, Human leukocyte pyrogen induces release of specific granule contents from human neutrophils, J. Clin. Invest. 61: 1330–1336.
Korsmeyer, S., Greene, W. C, Cossman, J., Hsu, S. M., Jensen, J. P., Neckers, L. M., Marshall, S. L., Bakshi, A., Depper, J. M., Leonard, W. J., Jaffe, E. S., and Waldmann, T. A., 1983, Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia, Proc. Natl. Acad. Sci. U.S.A. 80: 4522–4526.
Krane, S. M., 1975, Collagenase production by human synovial tissue, Ann. N. Y. Acad. Sci. 256: 289–303.
Kreuger, J. M., Walter, J., Dinarello, C. A., Wolff, S. M., and Chedid, L., 1985, Sleep promoting effects of endogenous pyrogen (interleukin-1), Am. J. Physiol, (in press).
Kronker, M., Depper, J. M., Leonard, W. J., Wong-Staal, F., Gallo, R. C., Waldmann, T. A., and Greene, W. C., 1984, Cyclosporin A inhibits interleukin-2 gene expression at the level of MRNA transcription, Lymphokine Res. 3:(abstract)253.
Lalande, M. E., McCutcheon, M. J., and Miller, R. G., 1980, Quantitative studies on the precursor of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 hr after stimulation, J. Exp. Med. 151: 12.
Larsson, E. L., and Contimiho, A., 1979, The role of mitogenic lectins in T-cell triggering, Nature 280: 239–241.
Leonard, W. J., Depper, J. M., Uchiama, T., Smith, K. A., Waldmann, T. A., and Greene, W. C., 1982, A monoclonal antibody that appears to recognize the receptor for human T cell growth factor. Partial characterization of receptor, Nature 300: 267–269.
Leonard, W. J., Depper, J. M., Robb, R. J., Waldmann, T. A., and Greene, W. C., 1983, Characterization of the human receptor for T cell growth factor, Proc. Natl. Acad. Sci. U.S.A. 80: 6957–6961.
Leonard, W. J., Depper, J. M., Crabtree, G. R., Rudukoff, S., Pumphery, J., Robb, R. J., Kronke, M., Setlik, P. B., Pegger, N. J., Waldmann, T. A., and Green, W. C., 1984, Molecular cloning and expression of cDNAs for the human interleukin-2 receptor, Nature 311: 626–631.
Lin, Y., Stadler, B. M., and Rabin, H., 1982, Synthesis of biologically active interleukin-2 by xenopus oocytes in response to poly A-RNA from a gibbon T cell line, J. Biol. Chem. 257: 1587–1590.
Linker-Israeli, M., Bakke, A. C., Kitridon, R. C., Gendler, S., Gillis, S., and Horowitz, D. A., 1983, Defective production of interleukin-1 and interleukin-2 in patients wih systemic lupus erythematosus, J. Immunol. 130: 2651–2655.
Lipsky, P. E., Thompson, P. A., Rossenwasser, L. J., and Dinarello, C. A., 1983, The role of interleukin-1 in human B cell activation: Inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukicytic pyrogen, J. Immunol. 130: 2708–2714.
Lugler, T. A., Charon, J. A., Colot, M., Micksche, M., and Oppenheim, J. J., 1983, Chemotactic properties of partially purified human epidermal cell-derived thymocyte activating factor (ETAF) for polymorphonuclear and mononuclear cells, J. Immunol. 131: 816–820.
MacDonald, H. R., Cerottini, J.-C., and Ryser, J. E., 1980, Quantitation and cloning of cytotoxic T lymphocytes and their precursors, Immunol. Rev. 51: 93–123.
Macphail, S., and Stutman, O., 1984, Independent inhibition of IL-2 synthesis and cell proliferation by anti- la antibodies in mixed lymphocyte response to MLs, Eur. J. Immunol. 14: 318–324.
Malek, T. R., and Shevach, E. M., 1984, Cellular and humoral requirements for the induction of IL-2 receptor expression on T cell subpopulations, Leukemia Res. 3: 257.
Malek, T. R., Robb, R. J., and Shevach, E. M., 1983, Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin-2 receptor-ligard complex, Proc. Natl. Acad. Sci. U.S.A. 80: 5694–5698.
Malek, T. R., Ortega, G., Jakway, J. P., Chan, C., and Shevach, E. M., 1984, The murine IL-2 receptor. II. Monoclonal anti-IL-2 receptor antibodies as specific inhibitors of T cell function in vitro, J. Immunol. 133: 1976–1982.
Mayernik, D. G., Hag, A., and Rinehart, J. J., 1984, Interleukin-1 secretion by human monocytes and macrophages, J. Leukocyte Biol. 36: 551–557.
Meuer, S. C., Hussey, R. E., Penta, A. C., Fitzgerald, K. A., Stadler, B. M., Schlossman, S. F., andReinherz, E. L., 1982, Cellular origin of interleukin-2 (IL-2) in man: Evidence for stimulus-restricted IL-2 production by T4+ and T8+ T lymphocytes, J. Immunol. 129: 1076–1079.
Mier, J. W., and Gallo, R. C., 1980, Purification and some properties of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte conditioned media, Proc. Natl. Acad. Sci. U.S.A. 77: 6134–6138.
Mier, J. W., and Gallo, R. C., 1982, The purification and properties of human T cell growth factor, J. Immunol. 128: 1122–1127.
Minato, N., Reid, L., and Blood, B. R., 1981, On the heterogeneity of murine natural killer cells, J. Exp. Med. 154: 750–762.
Miyasaka, N., Nakamura, T., Russell, I. J., and Talal, N., 1984, Interleukin-2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus, Clin. Immunol. Immunopathol. 31: 109–117.
Miyawaki, T., Yachie, A., Ohzeki, S., Nagaoki, T., and Taniguchi, N., 1983, Cyclosporin A does not prevent expression of Tac antigen, a possible TCGF receptor molecule, on mitogen-stimulated human T cells, J. Immunol. 130: 2727–2742.
Mizel, S. B., 1982, Interleukin-1 and T cell activation, Immunol. Rev. 63: 51–72.
Mizel, S. B., Dayer, J. M., Krane, S. M., and Mergenhagen, S. E., 1980, Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin- 1), Proc. Natl. Acad. Sci. U.S.A. 78: 2474–2477.
Morgan, D. A., Ruscetti, F. W., and Gallo, R. C., 1976, Selective in vitro growth of T lymphocytes from normal human bone marrow, Science 193: 1007–1009.
Nabel, G., Bucalo, L. R., Allard, J., Wigzell, H., and Cantor, H., 1981, Multiple activities of a clone cell line mediating natural killer cell function, J. Exp. Med. 153: 1582–1591.
Nabholz, M., Engers, M. D., Collavo, D., and North, M., 1978, Cloned T cell lines with specific cytotoxic activity, Curr. Top. Microbiol. Immunol. 81: 176–187.
Neefe, J. R., Curl, R., and Woody, J. N., 1981, Absolute requirement for adherent cells in the production of human interleukin-2 (IL-2) cell, Immunology 67: 71–80.
Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiama, T., Yodoi, J., and Honjo, T., 1984, Molecular cloning of cDNA encoding human IL-2 receptor, Nature 311: 631–635.
Nouri, A. M. E., Panayi, G. S., and Goodman, S. M., 1984a, Cytokines and chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluid, Clin. Exp. Immunol. 55: 295–302.
Nouri, A. M. E., Panayi, G. S., and Goodman, S. M., 1984b, Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids, Clin. Exp. Immunol. 58: 402–409.
Okada, M., and Henney, C. S., 1980, The differentiation of cytotoxic T cells in vitro. II. Amplifying factors) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Ly2+ cells but not Lytl+ cells, J. Immunol. 125: 300–307.
Okada, M., Klimpel, G. R., Kupper, R. C., and Henney, C. S., 1979, The differentiation of cytotoxic T cells in vitro. I. Amplifying factors) in the primary response is Lyt 1+ cell dependent, J. Immunol. 122: 2527–2533.
Oppenheim, J. J., Stadler, B M., Siraganian, R. P., Mage, M., and Mathieson, B., 1982, Lymphokines: Their role in lymphocyte response. Properties of interleukin-1, Fed. Proc. 41: 257–262.
Ortaldo, J. R., and Herberman, R. B., 1984, Heterogeneity of natural killer cells, Annu. Rev. Immunol. 2: 359–394.
Ortaldo, J. R., Mason, A. T., Gerard, J. P., Henderson, L. E., Farrar, W., Hopkins, R. F. Ill, Herberman, R. B., and Rabin, H., 1984, Effects of natural and recombinant IL-2 on regulation of IFNY production and natural killer activity: Lack of involvement of the Tac antigen for these immunoregulatory effects, J. Immunol. 133: 779–783.
Ortega, G., Robb, R. J., Shevach, E. M., and Malek, T. R., 1984, The murine IL-2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells, J. Immunol. 133: 1970–1975.
Osawa, H., and Diamantstein, T., 1983, Studies on T lymphocyte activation: II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2, an anti-IL-2 receptor antibody, Immunology 48: 617–621.
Osawa, H., and Diamantstein, T., 1984, A rat monoclonal antibody that binds specifically to mouse T lym-phoblasts and inhibits IL-2 receptor function: A putative anti-IL-2 receptor antibody, J. Immunol. 132: 2445–2450.
Paetkaun, V., Mills, G., Gerhart, S., and Monnticone, V., 1976, Proliferation of murine thymic lymphocytes in vitro is mediated by the Con A induced release of a lymphokine (co-stimulator), J. Immunol. 117: 1320–1324.
Palacios, R., and Moller, G., 1981, HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction, Cell Immunol. 63: 143–153.
Pfizenmaier, K., Schewich, P., Danbener, W., Kronke, M., Rollinghoff, M., and Wagner, H., 1984, Quan-titative representation of all T cell committed to develop into cytotoxic effector cells and/or interleukin-2 activity-producing helper cells within murine T lymphocyte subsets, Eur. J. Immunol. 14: 33–39.
Postlethwaite, A. E., Lachman, L. B., Mainardi, C. L., and Kang, A. H., 1983, Interleukin-1 stimulation of collagenase production by cultured fibroblasts, J. Exp. Med. 157: 801–806.
Puri, J., Shinitzky, M., and Conai, P., 1980, Concomitant increase in antigen binding and in T cell membranes lipid viscosity induced by the lymphocyte activating factor (LAF), J. Immunol. 124: 1937–1942.
Rafter, G. W., 1982, Etiology of rheumatoid arthritis, Med. Hypotheses 9: 437–443.
Raulet, D. M., and Bevan, M. J., 1982, A differentiation factor required for the expression of cytotoxic T cell function, Nature 269: 754–757.
Reem, G., and Yeh, N. H., 1984, Interleukin-2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes, Science 225: 429–430.
Reske-Kunz, A. B., Von Steldren, D., Rude, E., Osawa, H., and Diamentstein, T., 1984, Interleukin-2 receptors on an insulin-specific T cell clone: Dynamic of receptor expression, J. Immunol. 133: 1356–1361.
Robb, R. J., 1984, Interleukin-2: The molecule and its function, Immunol. Today 5: 203–209.
Robb, R. J., and Greene, W. C., 1983, Direct demonstration of the identity of T cell growth factor binding proterri and the Tac Antigen, J. Exp. Med. 158: 1332–1337.
Robb, R. J., and Smith, K. A., 1981, Human T-cell growth factor is glycosylated, Mol. Immunol. 18: 1087–1094.
Robb, R. J., Kutney, R. M., Panico, M., Morris, H., DeGrado, W. F., and Chowdlvey, V., 1983, Posttrans- lational modification of human-T cell growth factor, Biochem. Biophys. Res. Commun. 116: 1049–1055.
Robb, R. J., Greene, W. C., and Rusk, C. M., 1984, Low and high affinity cellular receptors for interleukin- 2. Implications for the level of Tac antigen, J. Exp. Med. 160: 1126–1146.
Ruscetti, F. W., Mier, J. W., and Gallo, R. C., 1980, Human T cell growth factor: Parameters for production, J. Supramol. Struct. 13: 229–241.
Salmeron, G., and Lipsky, P. E., 1983, Immunosuppressive potentials of antimalarials, Am. J. Med. 75: 19–24.
Santoro, T. J., Benjamin, W. R., Oppenheim, J. J., and Steinberg, A. D., 1983a, The cellular basis for immune interferon production in autoimmune MRL-lpr/lpr mice, J. Immunol. 131: 265–268.
Santoro, T. J., Luger, T. A., Ravache, E. S., Smolen, J. S., Oppenheim, J. J., and Steinberg, A. D., 1983b, In vitro correction of the interleukin-2 defect of autoimmune mice, Eur. J. Immunol. 13: 601–604.
Sarin, P. S., and Gallo, R. C., 1983, Human T-cell growth factor, CRC Crit. Rev. Immunol. 4: 279–305.
Sauder, D. H., 1984, Epidermal cytokines: Properties of epidermal cell thymocyte-activating factor (ETAF), Lymph Res. 4: 145–152.
Schmidt, J. A., Mizel, S. B., Cohen, D., and Green, I., 1982, Interleukin-1, a potent regulator of fibroblast- proliferation, J. Immunol. 128: 2177–2182.
Schrader, J. W., and Clark-Lewis, I., 1981, T-cell hybridoma derived regulatory factor. I. Production of T cell growth factor following stimulation by concanavalin A, J. Immunol. 126: 1101–1105.
Schreier, M. H., Iscove, N. N., Tees, R., Aarden, L., and VonBoehmer, H., 1980, Clones of killer and helper T cells: Growth requirements, specificity and retention of function in long term culture, Immunol. Rev. 51: 315–336.
Seigal, L. J., Harper, M. E., Wong-Staal, F., Gallo, R. C., Nash, W. G., and O’Brien, S. J., 1984, Gene for T cell growth factor: Location on human chromozone 4q and feline chromosome Bl, Science 223: 175–178.
Sibbitt, W. L., Jr., Likar, L., Spellman, C. W., and Bankhurst, A. D., 1983, Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production, Arthritis Rheum. 26: 1316–1320.
Sibbit, W. L., Kenny, C., Spellman, C. W., Ley, K. D., and Bankhurst, A. D., 1984, Lymphokines in autoimmunity: relationship between interleukin-2 and interferon-7 production in systemic lupus erythematosus, Clin. Immunol. Immunopathol. 32: 166–173.
Smith, K. A., 1984, Interleukin-2, Annu. Rev. Immunol. 2: 319–333.
Smith, K. A., Gillis, S., Baker, P. E., McKenzie, D., and Ruscetti, F. W., 1979, T-cell growth factor mediated T cell proliferation, Ann. N. Y. Acad. Sci. 332: 423–432.
Stadler, B. M., Dougherty, S. F., Farrar, J. J., and Oppenheim, J. J., 1981, Relationship of cell cycle to recovery of IL-2 activity from human mononuclear cells, human and mouse T cell lines, J. Immunol. 127: 1936–1940.
Stanley, E. R., Cifone, M., Heard, P. M., and Defendi, V., 1976, Factors regulating macrophage production and growth: Identity of colony-stimulating factor and macrophage growth factor, J. Exp. Med. 143: 631–647.
Symington, F. W., and Teh, H. S., 1980, A two signal mechanism for the induction of cytotoxic T lymphocytes, Scand. J. Immunol. 12: 1–12.
Talal, N., Dauphinee, M. J., and Wofsy, D., 1982, Interleukin-2 deficiency, genes, and systemic lupus erythematosus, Arthritis Rheum. 25: 838–842.
Taniguchi, T., Matsui, H., Fujita, T., Takaota, C., Hashima, N., Yoshimoto, R., and Hamuro, J., 1983, Structure and expression of a cloned cDNA for human interleukin-2, Nature 302: 305–309.
Teh, M. S., and Teh, S. J., 1980, Direct evidence for a two-signal mechanism of cytotoxic T cell activation, Nature 285: 163–165.
Teh, H. S., and Yu, M., 1983, Activation of nonspecific killer cells by interleukin-2-containing supernatants, J. Immunol. 131: 1827–1833.
Teh, M. S., Kwong, L., Yu, M., and Kilburn, D. G., 1981, A simple method for the quantitation of specific cytotoxic precursors to syngeneic tumors, J. Immunol. Methods 46: 97–111.
Ting, C. C., Yang, S. S., and Hargrove, M. E., 1984, Induction of suppressor T cells by interleukin-2, J. Immunol. 133: 261–266.
Trinchiari, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., and Perussia, B., 1984, Response of resting human peripheral blood natural killer cells to interleukin-2, J. Exp. Med. 160: 1147–1169.
Tsudo, M., Uchiama, T., and Uchino, H., 1984, Expression of Tac antigen on activated normal human B cells, J. Exp. Med. 160: 612–617.
Uchiama, T., Broder, S., and Waldmann, T. A., 1981a, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac(+) cells, J. Immunol. 126: 1393–1397.
Uchiama, T., Nelson, D. L., Fleisher, T. A., and Waldmann, T. A., 1981b, A monoclonal antibody (anti- Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, Suppressor cells and on one of two types of helper cells, J. Immunol. 126: 1398–1403.
Van Snick, J. L., Masson, P. L., and Heremans, J. F., 1974, The involvement of lactoferrin in the hyposideremia of acute inflammation, J. Exp. Med. 140: 1068–1084.
Vayuvegula, B., Butler, G., Chandy, K. G., Ruhling, M. L., and Gupta, S., 1985, Requirement of functional K+ channel for interleukin-1 production, Fed. Proc. 44: 1864 (Abstract).
Von Boehmer, H. S., Mengartner, H., Nabholz, M., Lenhardt, W., Schreier, M., and Haas, W., 1979, Fine specificity of a continuously growing killer cell clone specific for M-Y antigen, Eur. J. Immunol. 9: 592–597.
Waldmann, T. A., Goldman, C., Robb, R. J., Depper, J. M., Leonard, W. J., Sharrow, S. O., Bongiovanni, K. F., Korsmeyer, S. J., and Greene, W. C., 1984, Expression of interleukin-2 receptors on activated B cells, J. Exp. Med. 160: 1450–1466.
Wagner, H., and Rollinghoff, M., 1978, T cell interactions during in vitro cytotoxic allograft responses, J. Exp. Med. 148: 1523–1538.
Wagner, H. C., Herdt, C., Stockinger, M., Pfizenmaier, K., Bartlett, R., and Rollinghoff, M., 1981, Impact of the thymus on the generation of immunocompetence and diversity of antigen-specific MHC-restricted cytotoxic T lymphocyte precursors, Immunol. Rev. 58: 95–129.
Wagner, H. C., Hardt, C., Rouse, B. T., Rollinghoff, M., Schewrich, P., andPfzenmaier, K., 1982, Dissection of the proliferative and differentiation signals controlling murine cytotoxic T lymphocyte response, J. Exp. Med. 155: 1876–1881.
Welte, K., Wang, C. Y., Mertelsmann, R., Venuta, S., Feldman, S. P., and Moore, M. A., 1982, Purification of human interleukin-2 to apparent homogeneity and its molecular heterogeneity, J. Exp. Med. 156: 454–464.
Welte, K., Andreeff, M., Platzer, E., Holloway, K., Rubin, B. Y., Moore, M. A. S., and Merkelsmann, R., 1984, Interleukin-2 regulates the expression of Tac antigen on peripheral blood T lymphocytes, J. Exp. Med. 160: 1390–1403.
Wharton, W., 1983, Human macrophage-like cell line U937-1 elaborates mitogenic activity for fibroblasts, J. Reticuloendothel. Soc. 33: 151–156.
Wharton, W., Gillespie, G. Y., Russel, S. W., and Pledger, W. J., 1982, Mitogenic activity elaborated by macrophage-like cell lines acts as competence factors) for BALB/c 3T3 cells, J. Cell. Physiol. 110: 93–100.
Wilkins, J. A., Warrington, R. J., Sigurdson, S. L., and Rutherford, W. J., 1983, The demonstration of an interleukin-2 like activity in the synovial fluids of rheumatoid arthritis patients, J. Rheumatol. 10: 109–113.
Williams, N., Eger, R. R., Moore, M. A. S., and Mendelsohn, N., 1978, Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separated from WEH1-3 cell conditioned medium, Differentiation 11: 59–63.
Wofsy, D., Murphy, E. D., Roth, J. B., Dauphinee, M. J., Kipper, S. B., and Talal, N., 1981, Deficient interleukin-2 activity in MRL/MP and C57B1/6J mice bearing lpr gene, J. Exp. Med. 154: 1671–1680.
Wood, D. D., Ihrie, E. J., Dinarello, C. A., and Cohen, P. L., 1983, Isolation of an interleukin-1-like factor from human joint effusions, Arthritis Rheumat. 26: 975–983.
Zarling, J. M., and Bach, F. H., 1979, Continuous culture of T cells cytotoxic for autologous human leukemic cells, Nature 280: 685–687.
Zubler, R. H., Lowenthal, J. W., Erard, F., Hashimoto, N., Devos, R., and MacDonald, H. R., 1984, Activated B cells express receptors for, and proliferate in response to interleukin-2, J. Exp. Med. 160: 1170–1183.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Publishing Corporation
About this chapter
Cite this chapter
Gupta, S. (1985). Interleukins. In: Gupta, S., Talal, N. (eds) Immunology of Rheumatic Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2493-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2493-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9509-9
Online ISBN: 978-1-4613-2493-5
eBook Packages: Springer Book Archive